This functionality is implemented using Javascript. It cannot work without it, etc...

Estamos cargando la información...

Saltar al contenido

Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients with Cancer

Assay testing for determining 5-fluorouracil area under the curve in order to adjust 5-fluorouracil dose for individuals with cancer is considered investigational.

Testing for genetic variants in dipyrimidine dehydrogenase (DPYD) or thymidylate synthase (TYMS) genes to guide 5-fluorouracil dosing and/or treatment choice in individuals with cancer is considered investigational.

787-277-6653 787-474-6326